<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02861391</url>
  </required_header>
  <id_info>
    <org_study_id>0205-16-RMB</org_study_id>
    <nct_id>NCT02861391</nct_id>
  </id_info>
  <brief_title>Evaluation of the Safety and Efficacy of Carbon Dioxide (CO2) Acupulse Laser Treatment on Urinary Stress Incontinence.</brief_title>
  <official_title>Evaluation of the Safety and Efficacy of CO2 Acupulse Laser Treatment on Women With Urinary Stress Incontinence.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rambam Health Care Campus</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rambam Health Care Campus</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study is intended to assess the safety and efficacy of CO2 AcuPulse laser treatment in
      patients with urinary stress incontinence (USI). Eligible subjects will receive 3 treatment
      sessions, 4 weeks apart and 3 Follow Up visits, at 1, 3, and 6 months following the last
      treatment.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Following a screening visit and a urodynamic test, eligible subjects will be enrolled into
      the study. Eligibility will be decided depending on the level of USI the patient has. Each
      subject will receive 3 treatments 4 weeks apart and 3 Follow Up visits, at 1, 3, and 6 months
      following the last treatment.

      Further demographic information and patient history will be obtained from the subjects`
      electronical files.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 1, 2016</start_date>
  <completion_date type="Anticipated">April 1, 2019</completion_date>
  <primary_completion_date type="Anticipated">December 1, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The change in USI symptoms as measured by cough test</measure>
    <time_frame>8 months.</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>The change in USI symptoms as measured using quality of life questionnaires at the follow-up visits compared to baseline.</measure>
    <time_frame>8 months.</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Subject assessment of pain and discomfort that is procedure related using a Pain Visual Analogue Scale (VAS), evaluated at each treatment.</measure>
    <time_frame>2 months.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse events (AE's) and serious adverse events (SAE's).</measure>
    <time_frame>8 months.</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Exposure Laser</condition>
  <arm_group>
    <arm_group_label>CO2 AcuPulse Laser treatment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects with USI as diagnosed in urodynamic testing intended to receive 3 treatments 4 weeks apart and 3 Follow Up visits, at 1, 3, and 6 months following the last treatment.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>CO2 AcuPulse Laser</intervention_name>
    <description>Each subject will receive 3 treatments 4 weeks apart and 3 Follow Up visits, at 1, 3, and 6 months following the last treatment.</description>
    <arm_group_label>CO2 AcuPulse Laser treatment</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Negative urine culture.

          -  Positive for USI in urodynamic testing.

          -  Normal Papanicolaou (PAP) test from the recent year.

          -  Negative for vaginal wall prolapse.

          -  Able and willing to comply with the treatment/follow-up schedule and requirements.

        Exclusion Criteria:

          -  Pregnant subjects.

          -  Subjects with repeated urinary tract infections or repeated infections with Candida or
             Herpes (more than twice a year).

          -  Previous surgery in the treatment area in the previous 9 months.

          -  Unexplained vaginal bleeding.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lior Lowenstein, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rambam Health Care Campus</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Roy Lauterbach, MD</last_name>
    <phone>972529432416</phone>
    <email>r_lauterbach@rambam.health.gov.il</email>
  </overall_contact>
  <location>
    <facility>
      <name>Rambam health care campus</name>
      <address>
        <city>Haifa</city>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Roy Lauterbach, MD</last_name>
      <phone>0529432416</phone>
      <email>r_lauterbach@rambam.health.gov.il</email>
    </contact>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 25, 2016</study_first_submitted>
  <study_first_submitted_qc>August 5, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 10, 2016</study_first_posted>
  <last_update_submitted>March 11, 2018</last_update_submitted>
  <last_update_submitted_qc>March 11, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 13, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Rambam Health Care Campus</investigator_affiliation>
    <investigator_full_name>ROY LAUTERBACH MD</investigator_full_name>
    <investigator_title>Dr. Roy Lauterbach</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Urinary Incontinence, Stress</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

